Jfl Life Sciences Limited Share Price & Stock Analysis

Jfl Life Sciences Limited (NSE: JFLLIFE) is an Ahmedabad, Gujarat-based company in the Pharmaceuticals industry. With a market capitalisation of ₹45 Cr, it ranks #3,867 by market cap among the 6,197 Indian listed companies on FinBizNet, and #52 of 63 in Pharmaceuticals. At ₹13.50 (as of 16 Nov 2026), the share price is 12.3% below its 52-week high of ₹15.40 and 57.9% above its 52-week low of ₹8.55. The share price is down 0.4% over one year and up 3.9% over three months.

Key Metrics

Current Price₹13.50
Market Cap₹45 Cr
NSE SymbolJFLLIFE
SectorHealth Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals
Sub-IndustryBiotechnology and Life Sciences > Pharmaceuticals
P/E Ratio7
Return on Equity15.00%
Return on Assets7.46%
52-Week Range₹8.55 – ₹15.40
1-Year Price Change-0.4%
3-Month Price Change+3.9%
Beta (1Y)-0.11
Dividend Yield0.00%
HeadquartersAhmedabad, Gujarat
Websitejfllifesciences.com

Latest Quarterly Results — Q2 FY27

Revenue₹99 Cr
Net Profit₹5 Cr
Net Margin5.2%
EPS (Basic)₹1.28
Basisstandalone

Figures in ₹ crore, parsed from the company's exchange filing (XBRL).

Jfl Life Sciences Limited Quarterly Revenue and Profit Trend

Jfl Life Sciences Limited reported revenue of ₹99 Cr in Q2 FY27, up 229.8% from ₹30 Cr in Q2 FY26 and up 788.7% from ₹11 Cr in Q1 FY27. It posted a net profit of ₹5 Cr for the quarter, against a net profit of ₹2 Cr in Q2 FY26 (up 159.1%). Across the 6 quarters from Q1 FY26 to Q2 FY27, quarterly revenue ranged from ₹11 Cr (Q1 FY27) to ₹99 Cr (Q2 FY27). The company was profitable in each of these 6 quarters.

QuarterRevenueNet ProfitNet Margin
Q2 FY27₹99 Cr₹5 Cr5.2%
Q1 FY27₹11 Cr₹1 Cr10.0%
Q4 FY26₹63 Cr₹2 Cr2.6%
Q3 FY26₹27 Cr₹2 Cr7.5%
Q2 FY26₹30 Cr₹2 Cr6.6%
Q1 FY26₹12 Cr₹1 Cr6.5%

Standalone figures (₹ crore, XBRL filings).

Shareholding and Delivery

Promoters held 67.47% of Jfl Life Sciences Limited's shares as of Sept 2026, unchanged from Sept 2025.

About Jfl Life Sciences Limited

JFL Life Sciences Limited manufactures and sells pharmaceutical products in India and internationally. The company offers beta lactam dry powder injections, beta lactam tablets and capsules in solid oral dosage form, oral rehydration solutions, and general tablets and capsules. It also exports its products to Africa, the Middle East, and CIS countries through merchant exporters. JFL Life Sciences Limited was incorporated in 2010 and is headquartered in Ahmedabad, India.

Products and Services

1. Pharmaceuticals Manufacturing-This segment manufactures and sells pharmaceutical products. 2. NA-NA 3. NA-NA 4. NA-NA

Business Segments

1. Pharmaceuticals Manufacturing-100%

Jfl Life Sciences Limited vs Peers — Pharmaceuticals

CompanyMarket CapP/EROELatest Qtr Revenue1Y Change
Abbott India Ltd.₹56,531 Cr36.334.46%₹1,814 Cr-8.1%
Emcure Pharmaceuticals Ltd₹42,344 Cr47.919.57%₹2,820 Cr+73.3%
Ajanta Pharma Limited₹41,474 Cr39.425.39%₹1,794 Cr+27.8%
Piramal Pharma Ltd₹32,600 Crn/m-4.00%₹2,617 Cr+22.8%
RUBICON RESEARCH LIMITED₹28,526 Cr112.319.14%₹576 Cr+162.7%
Caplin Point Laboratories Ltdte₹18,155 Cr28.319.94%₹630 Cr+23.6%
Pfizer Ltd.₹17,811 Cr24.517.16%₹727 Cr-24.2%
Eris Lifesciences Ltd₹17,691 Cr28.318.07%₹892 Cr-17.5%
Jfl Life Sciences Limited₹45 Cr715.00%₹99 Cr-0.4%

Listed by market capitalisation. Ratios are shown for context only.

Frequently Asked Questions

What is the current share price of Jfl Life Sciences Limited?

Jfl Life Sciences Limited is trading at ₹13.50, with a market capitalisation of ₹45 Cr.

Which sector does Jfl Life Sciences Limited belong to?

Jfl Life Sciences Limited operates in the Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals space (Biotechnology and Life Sciences > Pharmaceuticals).

What are the key financial ratios of Jfl Life Sciences Limited?

Jfl Life Sciences Limited has a P/E of 7 and a return on equity of 15.00%.

What is the stock symbol of Jfl Life Sciences Limited?

Jfl Life Sciences Limited is listed on the NSE under the symbol JFLLIFE.

How has Jfl Life Sciences Limited's share price moved over the past year?

Jfl Life Sciences Limited's share price is down 0.4% over one year and up 3.9% over three months. Its 52-week range is ₹8.55 to ₹15.40.

What were Jfl Life Sciences Limited's latest quarterly results?

In Q2 FY27, Jfl Life Sciences Limited reported revenue of ₹99 Cr and net profit of ₹5 Cr, with basic EPS of ₹1.28 (standalone, parsed from the company's exchange filing).

How have Jfl Life Sciences Limited's revenue and profit changed over the past year?

Jfl Life Sciences Limited reported revenue of ₹99 Cr in Q2 FY27, up 229.8% from ₹30 Cr in Q2 FY26 and up 788.7% from ₹11 Cr in Q1 FY27.

What is the promoter holding in Jfl Life Sciences Limited?

Promoters held 67.47% of Jfl Life Sciences Limited's shares as of Sept 2026, unchanged from Sept 2025.

More on FinBizNet

Data as of 16 Nov 2026. Descriptive market data only — not investment advice.